<code id='2C872BED7F'></code><style id='2C872BED7F'></style>
    • <acronym id='2C872BED7F'></acronym>
      <center id='2C872BED7F'><center id='2C872BED7F'><tfoot id='2C872BED7F'></tfoot></center><abbr id='2C872BED7F'><dir id='2C872BED7F'><tfoot id='2C872BED7F'></tfoot><noframes id='2C872BED7F'>

    • <optgroup id='2C872BED7F'><strike id='2C872BED7F'><sup id='2C872BED7F'></sup></strike><code id='2C872BED7F'></code></optgroup>
        1. <b id='2C872BED7F'><label id='2C872BED7F'><select id='2C872BED7F'><dt id='2C872BED7F'><span id='2C872BED7F'></span></dt></select></label></b><u id='2C872BED7F'></u>
          <i id='2C872BED7F'><strike id='2C872BED7F'><tt id='2C872BED7F'><pre id='2C872BED7F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:65
          Illustration of business people chasing flying money with butterfly nets
          Adobe

          SAN FRANCISCO — Hospital leaders spent a good chunk of their stage time at the J.P. Morgan Healthcare Conference talking up their billions in cash and investment reserves.

          It’s a decidedly different message than the one they convey to their communities, or to Congress when they lobby for more funding. But at the high-profile health care industry conference here, nonprofit health systems need to sell investors on their message of strength and resilience. And since they certainly can’t do that by focusing on patient care — an area where they’re barely breaking even or losing money — cash and investments is the way to do it.

          advertisement

          “For those of you who hold our debt, taxable and tax-exempt, thank you,” John Mordach, the chief financial officer of Jefferson Health, said during his presentation on Tuesday. “For those who don’t, I think we’re a great, undervalued investment and we get a great return.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Listen: Vivek Ramaswamy's star turn & leaky drug data
          Listen: Vivek Ramaswamy's star turn & leaky drug data

          Doesbiotechprepareyouforthepresidency?WhoreallywantstoguttheFDA?AndwhydodrugcompaniesstrugglewithIT?

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          PBMs are inflating the cost of generic drugs. They must be reined in

          AdobeThesearenotcomfortabledaysinWashingtonforpharmacybenefitmanagers,thehighlyconsolidatedgroupofin